SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001384101-24-000051
Filing Date
2024-04-17
Accepted
2024-04-17 16:34:49
Documents
17
Period of Report
2024-02-05
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A vcyt-20240205.htm   iXBRL 8-K/A 33940
2 EX-23.1 ex231c2ifinancialsconsent.htm EX-23.1 5623
3 EX-99.1 ex991c2igenomics2023.htm EX-99.1 399489
4 EX-99.2 ex9922023proformastatements.htm EX-99.2 326818
8 GRAPHIC eyheader.gif GRAPHIC 7434
  Complete submission text file 0001384101-24-000051.txt   978641

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcyt-20240205.xsd EX-101.SCH 1917
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcyt-20240205_lab.xml EX-101.LAB 23661
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcyt-20240205_pre.xml EX-101.PRE 13583
20 EXTRACTED XBRL INSTANCE DOCUMENT vcyt-20240205_htm.xml XML 4977
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

IRS No.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36156 | Film No.: 24851564
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)